# Safety and Efficacy of Multiple Doses of Intranasal Ketorolac in Postoperative Pain Following Major Abdominal Surgery

> **NCT00266786** · PHASE3 · COMPLETED · sponsor: **Egalet Ltd** · enrollment: 321 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Intranasal Ketorolac Tromethamine
- **DRUG:** Intranasal Placebo

## Key facts

- **NCT ID:** NCT00266786
- **Lead sponsor:** Egalet Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-02
- **Final completion:** —
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2017-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00266786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00266786, "Safety and Efficacy of Multiple Doses of Intranasal Ketorolac in Postoperative Pain Following Major Abdominal Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00266786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*